RISE study of 700 Pegloticase users (14 mos F/U) found 18% on immunosuppressive (MTX, MMF, LEF), these had signif less PEG D/C (HR 0.52-0.69). Immunosuppressives not assoc w/ more lab abnormalities https://t.co/4ytot7HOMh https://t.co/0wrjvnZur3
Links:
Real‐World Effectiveness of Pegloticase Associated with Use of Concomitant Immu…
https://buff.ly/4bfKKHB
May-13-2024
